Stockreport

Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]

Vivani Medical, Inc.  (VANI) 
PDF Positive NPM-115 (exenatide implant) preclinical weight loss data comparable to semaglutide, active ingredient in Ozempic ® /Wegovy ® $15 million financing round enab [Read more]